The Column Group — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Ngm BiopharmaceuticalsOct 2014SEC filinghigh confidence
BiotechSouth San Francisco, US
Jin-Long Chen(Executive Officer, Director)William J. Rieflin(Executive Officer, Director)David V. Goeddel(Director)
BoardMark Leschly(Director)David Schnell(Director)
Board seatDavid GoeddelPeter Svennilson· per SEC Form D · $60M raise · filed Feb 2015
Co-investorsForesite CapitalProspect Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.